naltrexone showed no clear difference in retention and abstinence, all patients compared with placebo or no pharmacological treatments; GRADE not reported.
naltrexone showed no clear difference in abstinence at compared with placebo or no pharmacological treatments; GRADE not reported.
naltrexone showed no clear difference in side effects compared with placebo or no pharmacological treatments; GRADE not reported.
Summary of findings for the main comparisons: Antagonost (Naltrexone) probably leads to lower criminal activity dichotomous ‐ Reincarceration official records compared with no pharmacological (moderate certainty).
Summary of findings for the main comparisons: Antagonost (Naltrexone) showed no clear difference in drug use (objective) urine screen compared with no pharmacological (low certainty).